ACS03
ACS03 is a hybrid thiophene-acridine compound. ACS03 induces an increase in lactate dehydrogenase, glutathione S-transferase, and AChE activities. ACS03 has antileishmanial activity. ACS03 exhibits selective anti-cancer effects against colon carcinoma[1].
Product Specifications
CAS Number
2227022-64-0
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Glutathione S-transferase; Lactate Dehydrogenase; Parasite
Related Pathways
Anti-infection; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Cancer; Infection
Smiles
COC(C=CC1=NC2=CC(Cl)=CC=C23)=CC1=C3NC(SC4=C5CCCCC4)=C5C#N
Molecular Formula
C24H20ClN3OS
Molecular Weight
433.95
References & Citations
[1]Lisboa T, et al. Toxicity and Antitumor Activity of a Thiophene-Acridine Hybrid. Molecules. 2019 Dec 24;25 (1) :64.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AChE; Leishmania
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS002849-100ug 100 µg
GPR26 (NM_153442) Human Over-expression Lysate
Sign In for Pricing
View Details 
